Reabilitação física na Esclerose Lateral Amiotrófica
DOI:
https://doi.org/10.34024/rnc.2009.v17.8601Palavras-chave:
Esclerose Amiotrófica Lateral, Doenças Neuromusculares, Fisioterapia, ReabilitaçãoResumo
Objetivo. Atentar aos profissionais de saúde engajados com a reabilitação física, sobre os riscos existentes no tratamento de pacientes com ELA no que diz respeito ao uso excessivo ou a atrofia por desuso. Método. Foram pesquisados os artigos no período de 1958 a 2006 localizados nas bases de dados Bireme, SciELO, Pubmed, Lilacs, por meio dos seguintes descritores: esclerose amiotrófica lateral, doenças neuromusculares, fadiga, fraqueza muscular, atividade física, reabilitação, fisioterapia. Resultados. O tratamento da ELA visa a prevenção da fadiga e dos danos pelo uso excessivo, além de otimizar a independência e a capacidade funcional, através de exercícios moderados, alongamentos, equipamentos de assistência e fisioterapia respiratória. Conclusão. Embora não haja muitos estudos de intervenção envolvendo exercícios para ganho de força em indivíduos com ELA devido ao curso variável e ao envolvimento bulbar, o fisioterapeuta, ao propor programas com tal finalidade, deve utilizar exercícios em níveis submáximos na esperança de atenuarem a perda de força, considerando a prevenção do uso excessivo e da atrofia por desuso e atentando sempre para o gerenciamento adequado destes.
Downloads
Métricas
Referências
Cassemiro CR, Arces CG. Comunicação visual por computador na esclerose Lateral Amiotrófica. Arq Bras Oftalmol 2004;67:295-300.
Voltarelli JC. Perspectivas de terapia celular na esclerose lateral amiotrófica. Rev Bras Hematol Hemoter 2004; 26(3):155-6.
Urhán A, Herrera DA, Vargas S. Esclerosis Lateral Amiotrófica. Rev Colomb Radiol 2002;13(4):1276-9.
Buttarelli FR, Circella A, Pellicano C, Pontieri FE. Dopamine transporter immunoreactivity in peripheral blood mononuclear cells in amyotrophic lateral sclerosis. Eur J Neurol 2006;13(4):416-8.
Neto FD, Callegaro D, Dias-Tosta E, Silva HA , Ferraz ME, Lima JMB, et al. Amyotrophic Lateral Sclerosis in Brazil – 1998 National Survey. Arq Neuropsiquiatr 2000; 58(3-A):607-15.
Calzada-Sierra DJ, Goméz-Ferenández L. Importancia del tratamiento rehabilitador multifactorial en la esclerosis lateral amiotrófica. Rev Neurol 2001;32:423-6.
Rocha JA, Reis C, Simoes F, Fonseca J, Mendes Ribeiro J. Diagnostic investigation and multidisciplinary management in motor neuron disease. J Neurol 2005;252(12):1435-47.
Fowler WM. Role of physical activity and exercise training in neuromuscular diseases. Am J Phy Med Rehabil 2002;81(11 Suppl):S187-95.
Schulte-Mattler WJ, Muller T, Deschauer M, Gellerich FN, Iaizzo PA, Zierz S. Increased metabolic muscle fatigue is caused by some but not all mitochondrial muatations. Arch Neurol 2003;60:50-8.
Van Engelen BG, Kalkman JS, Schillings ML, Van Der Werf SP, Bleijenberg G, Zwarts MJ. Fatigue in neuromuscular disease. Ned Tijdschr Geneeskd 2004;148:1336-41.
Layzer RB. Muscle pain, cramps, and fatigue. In: Engel AG, FranziniAmstrong C (eds.). Myology. New York: McGraw-Hill, 1994, 1754-68.
Baker AJ, Carson PJ, Miller RG, Wein MW. Metabolic and nonmetabolic components of fatigue monitored with 31p-NMR. Muscle Nerve 1994;17:1002-9.
Miller RG, Green AT, Moussavi RS, Carson PJ, Weiner MW. Excessive muscular fatigue in patients with spastic paraparesis. Neurology 1990;40:1271-4.
Sharma KR, Kent-Braun JA, Majumdar S, Huang Y, Mynhier M, Weiner MW, et al. Physiology of fatigue in amyotrophic lateral sclerosis. Neurology 1995;45:733-40.
Borg K, Edstrom L. Prior poliomyelitis: an immunohistochemical study of cytoskeletal proteins and a marker for muscle fibre regeneration in relation to usage of remaining motor units. Acta Neurol Scand 1993;87:128-32.
Borg K, Borg J, Dhoot G, Edstrom L, Grimby L, Thornell LE. Motoneuron firing and isomyosin type of muscle fibers in prior polio. J Neurol Neurosurg Psychiatry 1989;52:1141-8.
Hallum A. Doenças neuromusculares. In: Umphred DA. Reabilitação Neurológica. 4ª. ed. São Paulo: Manole, 2004, 384-440.
Kilmer DD, Aitkens S. Neuromuscular disease. In: Frontera WR, Dawson DM, Slovik DM. Exercise in Rehabilitation Medicine. Champaign: Human Kinetics, 1999, 253-66.
Russell J. Blattner Spencer WA. The treatment of acute poliomyelitis. Springfield: Charles C Thomas, 1954, 530p.
Bennett R L, Knowlton GC. Overwork weakness in partially denervated skeletal muscle. Clin Orthop 1958;12: 22-9.
Sanjak M, Paulson D, Sufit R, Reddan W, Beaulieu D, Erickson L, et al. Physiologic and metabolic response to progressive and prolonged exercise in amyotrophic lateral sclerosis. Neurology 1987;37:1217-20.
Gomes MM. Envelhecimento e o aumento das doenças amiotróficas: epidemiologia das doenças (crônicas) das células do corno anterior da medula. Arq Bras Med 1991;65:589-94.
Guccione AA. Physical therapy diagnosis and the relationship between impairments and function. Phys Ther 1991;71:499-504.
Cedarbaum JM, Stambler N, Malta E, Fuller C, Hilt D, Thurmond B, et al. The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III). J Neurol Sci 1999;169(1-2):13-21.
McGuire D, Garrison L, Armon C, Barohn R, Bryan W, Miller R, et al. Relationships of the Tufts Quantitative Neuromuscular Exam (TQNE) and the Sicknes Impact Profile (SIP) in measuring progression of ALS.
SSNJVCNTF ALS Study Group. Neurology 1996;46(5):1442-4.
Brinckmann JR, Andres P, Mendonza M, Sanjak M. Guidelines for the use and performance of quantitaive outcome measure in ALS clinical trials. J Neurol Sci 1997;147:97-111.
Lacomblez L, Bensimon G, Leigh PN, Guillet P, Meininger V. Doseranging study of riluzole in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis/Riluzole Study Group II. Lancet 1996;347:1425-31.
Olarte MR, Shaffer SQ. Levamisole is ineffective in the treatment of amyotrophic lateral sclerosis. Neurology 1985;35:1063-6.
Desnuelle C, Dib M, Garrel C, Favier A. A double-blind, placebocontrolled randomized trial of alfa-tocopherol (vitamin E) in the treatment of amyotrophic lateral sclerosis. ALS riluzole-tocopherol Study Group.
Amyotroph Lateral Scler Other Motor Neuron Disord 2001;2:9-18.
Keith RA, Granger CV, Hamilton BB, Sherwin FS. The functional independence measure: a new tool for rehabilitation. Adv Clin Rehabil 1987;1:6-18.
Mahoney FI, Barthel DW. Functional evaluation: Barthel index. Md State Med J 1965;14:61-5.
Wrigth W. Muscle training in the treatment of infantile paralysis. Boston Med Surg J 1912;167:567.
Mendell J, Florence J. Manual muscle testing. Muscle Nerve 1990;13(Suppl):S16-20.
Brooks BR, Sufit RL, DePaul R, Tan YD, Sanjak M, Robbins J. Design of clinical therapeutic trials in amyotrophic lateral sclerosis. Adv Neurol 1991;56:521-46.
Beck M, Giess R, Wurffel W, Magnus T, Ochs G, Toyka KV. Comparison of maximal voluntary isometric contraction and Drachman’s hand-held dynamometry in evaluating patients with amyotrophic lateral
sclerosis. Muscle Nerve 1999;22:1265-70.
Sinaki M. Rehabilitation. In: Mulder DW. The Diagnosis and Treatment of Amyotrophic Lateral Sclerosis. Boston: Houghton Mifflin Co, 1980, 171-93.
Dal Beelo-Haas V, Kloos AD, Mitsumoto H. Physical Therapy for a Patient Through Six Stages of Amyotrophic Lateral Sclerosis. Phys Ther 1998;78(12):1312-24.
Sinaki M, Mulder DW. Rehabilitation techniques for patients with amyotrophic lateral sclerosis. Mayo Clin Proc 1978;53:173-8.
Orient-López F, Terré-Boliart R, Guevara-Espinosa D, BernabeuGuitart. Tratamiento neurorrehabilitador de la esclerosis lateral amiotrófica. Rev Neurol 2006;43(9):549-55.
Smith RA, Norris FH. Symptomatic care of patients with amyotrophic lateral sclerosis. JAMA 1975;234:715-7.
Wagner MB, Vignos PJ, Fonow DC . Serial isokinetic evaluations used for a patient with scapuloperoneal muscular dystrophy: a case report. Phys Ther 1986;66:1110-3.
Norris FH. Exercise for patients with neuromuscular diseases. West J Med 1985;142:261.
Bohannon RW. Results of resistance exercise on a patient with amyotrophic lateral sclerosis: a case report. Phys Ther 1983;63:965-8.
Kilmer DD, McCrory MA, Wright NC, Aitkens SG, Bernauer EM. The effect of a high resistance exercise program in slowly progressive neuromuscular disease. Arch Phys Med Rehabil 1994;75:560-3.
Drory VE, Goltsman E, Reznik JG, Mosek A, Korczyn AD. The value of muscle exercise in patients with amyotrophic lateral sclerosis. J Neurol Sci 2001;191(1-2):133-7.
Aitkens SG, McCrory MA, Kilmer DD, Bernauer EM. Moderate resistance exercise program: its effect in slowly progressive neuromuscular disease.Arch Phys Med Rehabil 1993;74(7):711-5.
Milner-Brown HS, Miller RG. Muscle strengthening through electric stimulation combined with low-resistance weights in patients with neuromuscular disorders. Arch Phys Med Rehabil 1988;69:20-4.
Wright NC, Kilmer DD, McCrory MA, Aitkens SG, Holcomb BJ, Bernauer EM. Aerobic walking in slowly progressive neuromuscular disease: effect of a 12-week program. Arch Phys Med Rehabil 1996;77:64-9.
Florence JM, Hagberg JM. Effect of training on the exercise responses of neuromuscular disease patients. Med Sci Sports Exerc 1984;16:460-5.
Desnuelle C, Bruno M, Soriani MH, Perrin C. Quelles sont les modalités de thérapie physique symptomatique incluant les techniques de désencombrement bronchique? Rev Neurol (Paris) 2006;162(Spec 2):4S244-52.
Frownfelter D, Dean E. Principle and Practice of Cardiopulmonary Physical Therapy. 3rd ed. St Louis: CV Mosby Co, 1996, 435p.
Bach JR, Rajaraman R, Ballanger F, 6 autores, et al. Neuromuscular ventilatory insufficiency: the effect of home mechanical ventilator use vs oxygen therapy on pneumonia and hospitalization rates. Am J Phys
Med Rehabil 1998;77:8-19.
Tzeng AC, Bach JR. Prevention of pulmonary morbidity for patients with neuromuscular disease. Chest 2000; 118(5):1390-6.
Ioos C, Leclair-Richard D, Mrad S, Barois A, Estournet-Mathiaud B. Respiratory capacity course in patients with infantile spinal muscular atrophy. Chest 2004;126(3):831-7.
Tangsrud SE, Carlsen KC, Lund-Petersen I, Carlsen KH. Lung function measurements in young children with spinal muscle atrophy; a cross sectional survey on the effect of position and bracing. Arch Dis Child 200; 84(6): 521-4.
Miske LJ, Hickey EM, Kolb SM, Weiner DJ, Panitch HB. Use of the mechanical in-exsufflator in pediatric patients with neuromuscular disease and impaired cough. Chest 2004;125(4):1406-12.
Koessler W, Wanke T, Winkler G, Nader A, Toifl K, Kurz H, et al. 2 Years’ experience with inspiratory muscle training in patients with neuromuscular disorders. Chest 2001;120(3):765-9.
Downloads
Publicado
Como Citar
Edição
Seção
Publicado: 2009-03-31